Brian C Gilger
Overview
Explore the profile of Brian C Gilger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Young K, Hasegawa T, Vridhachalam N, Henderson N, Salmon J, McCall T, et al.
Mol Ther Methods Clin Dev
. 2024 Dec;
32(4):101360.
PMID: 39703903
Non-infectious uveitis (NIU) is a painful recurrent disease affecting 2%-5% of horses. Current treatments require frequent administration with associated adverse events. In a previous study, intravitreal (IVT) adeno-associated virus (AAV)...
2.
3.
Smith H, Love K, Antezana A, Barr E, Gilger B, Oh A
J Am Vet Med Assoc
. 2024 Oct;
262(S2):S74-S84.
PMID: 39442544
Objective: To determine clinical outcome, treatment costs, and hospitalization duration in horses treated for keratomycosis and identify ophthalmic examination and diagnostic results associated with these outcomes. Methods: This was a...
4.
Smith H, Love K, Antezana A, Barr E, Gilger B, Oh A
J Am Vet Med Assoc
. 2024 Sep;
262(S2):S85-S93.
PMID: 39326460
Objective: The primary aims were to provide descriptive data on systemic and ocular complications associated with the treatment of equine keratomycosis. The secondary aims were to determine if complication rates...
5.
Gilger B, Hasegawa T, Sutton R, Bower J, Li C, Hirsch M
Mol Ther
. 2024 Sep;
32(11):4006-4020.
PMID: 39245940
Corneal blindness affects more than 5 million individuals, with over 180,000 corneal transplantations (CTs) performed annually. In high-risk CTs, almost all grafts are rejected within 10 years. Here, we investigated...
6.
Gould J, Wells M, de Linde Henriksen M, Gilger B
J Am Vet Med Assoc
. 2024 Jul;
262(S2):S94-S101.
PMID: 39047776
Objective: To determine the causes, time to resolution, effect of therapeutics, and ocular sequelae of hyphema, fibrin, and/or vitreal hemorrhage in horses. Animals: 225 horses (219 eyes) who were diagnosed...
7.
Roberts D, Gilger B
J Am Vet Med Assoc
. 2024 Jul;
262(S2):S65-S73.
PMID: 38991540
Equine fungal keratitis represents a substantial portion of keratitis cases in horses, with fungal involvement identified in approximately half of all infectious keratitis cases. Despite its prevalence, more comprehensive retrospective...
8.
Roberts D, Thomas J, Salmon J, Cubeta M, Stapelmann K, Gilger B
J Med Microbiol
. 2024 Jul;
73(7).
PMID: 38985505
and are common causative pathogens of fungal keratitis (FK), a severe corneal disease associated with significant morbidity and vision loss. Escalating incidence of antifungal resistance to available antifungal drugs poses...
9.
Collins E, Barr E, Westermeyer H, Gilger B, Oh A
J Am Vet Med Assoc
. 2024 May;
262(S2):S57-S64.
PMID: 38821111
Objective: To determine the predictive value of corneal ultrasound biomicroscopy (UBM) findings for the outcome of equine corneal disease. Animals: 46 horses with a clinical diagnosis of either infectious ulcerative...
10.
Roberts D, Salmon J, Cubeta M, Gilger B
J Fungi (Basel)
. 2023 Oct;
9(10).
PMID: 37888221
Fungal keratitis (FK) is an invasive infection of the cornea primarily associated with and species. FK is treated empirically with a limited selection of topical antifungals with varying levels of...